Company Info
Phone(617) 658-0600
Year Established
2009
Ticker
KPTI
Exchange
NASDAQ
Contacts
Richard Paulson, MBA, PhDPresident & CEO
Stuart Poulton
Chief Development Operations Officer
Mike Mano, JD
General Counsel
Michael Mason, MBA, CPA
CFO
Sohanya Cheng
CCO
Reshma Rangwala, MD, PhD
CMO
Jessie Yeung
Interim CFO
Company Description
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions.
